{"title":"Vacuolar protein sorting 13 homolog C was associated with motor progression in Parkinson's disease","authors":"Xin Guo , Bin Teng , Jianfang Ma","doi":"10.1016/j.parkreldis.2024.107253","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>The SNP rs2414739 of Vacuolar protein sorting 13 homolog C(VPS13C) gene was identified to be linked with Parkinson's Disease (PD).</div></div><div><h3>Objectives</h3><div>Explore the clinical progression feature of PD patients with rs2414739 variant.</div></div><div><h3>Methods</h3><div>Longitudinal data were obtained from the Parkinson's Progression Marker Initiative (PPMI) cohorts. Linear mixed models were used to test the effects of <em>VPS13C</em> with the progression of PD assessed by different scales.</div></div><div><h3>Result</h3><div>A total of 333 patients with PD were included and divided into rs2414739 carriers (n = 138) and noncarriers (n = 195). Patients with PD carrying <em>VPS13C</em> mutation had slower progression, assessed by total scores of MDS-UPDRS (II+III) (β = −1.834, p = 0.000, 95%CI: −2.767, −0.901) than noncarriers. The effect of <em>VPS13C</em> was significant both in the rate of change of UPDRS-II scores (β = −0.284, p = 0.028, 95%CI: −0.537, −0.031) and UPDRS-III scores (β = −0.894, p = 0.009, 95%CI: −1.558, −0.228). We further divided VPS13C carriers into heterozygous and homozygous carriers, and found that the rate of change of UPDRS(II+III) (β = −1.165, p = 0.039, 95%CI: −2.265,−0.062) scores and UPDRS-III scores (β = −9.521, p = 0.041, 95%CI: −18.524,−0.532) were significantly slow in heterozygous VPS13C carriers. There was only 20 homozygous VPS13C carriers, which was too small a sample to perform the analysis.</div></div><div><h3>Conclusion</h3><div><em>VPS13C</em> was associated with slow motor progression in PD patients.</div></div>","PeriodicalId":19970,"journal":{"name":"Parkinsonism & related disorders","volume":"131 ","pages":"Article 107253"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parkinsonism & related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1353802024012653","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
The SNP rs2414739 of Vacuolar protein sorting 13 homolog C(VPS13C) gene was identified to be linked with Parkinson's Disease (PD).
Objectives
Explore the clinical progression feature of PD patients with rs2414739 variant.
Methods
Longitudinal data were obtained from the Parkinson's Progression Marker Initiative (PPMI) cohorts. Linear mixed models were used to test the effects of VPS13C with the progression of PD assessed by different scales.
Result
A total of 333 patients with PD were included and divided into rs2414739 carriers (n = 138) and noncarriers (n = 195). Patients with PD carrying VPS13C mutation had slower progression, assessed by total scores of MDS-UPDRS (II+III) (β = −1.834, p = 0.000, 95%CI: −2.767, −0.901) than noncarriers. The effect of VPS13C was significant both in the rate of change of UPDRS-II scores (β = −0.284, p = 0.028, 95%CI: −0.537, −0.031) and UPDRS-III scores (β = −0.894, p = 0.009, 95%CI: −1.558, −0.228). We further divided VPS13C carriers into heterozygous and homozygous carriers, and found that the rate of change of UPDRS(II+III) (β = −1.165, p = 0.039, 95%CI: −2.265,−0.062) scores and UPDRS-III scores (β = −9.521, p = 0.041, 95%CI: −18.524,−0.532) were significantly slow in heterozygous VPS13C carriers. There was only 20 homozygous VPS13C carriers, which was too small a sample to perform the analysis.
Conclusion
VPS13C was associated with slow motor progression in PD patients.
期刊介绍:
Parkinsonism & Related Disorders publishes the results of basic and clinical research contributing to the understanding, diagnosis and treatment of all neurodegenerative syndromes in which Parkinsonism, Essential Tremor or related movement disorders may be a feature. Regular features will include: Review Articles, Point of View articles, Full-length Articles, Short Communications, Case Reports and Letter to the Editor.